SE8405500L - Diagnosticeringspartiklar - Google Patents
DiagnosticeringspartiklarInfo
- Publication number
- SE8405500L SE8405500L SE8405500A SE8405500A SE8405500L SE 8405500 L SE8405500 L SE 8405500L SE 8405500 A SE8405500 A SE 8405500A SE 8405500 A SE8405500 A SE 8405500A SE 8405500 L SE8405500 L SE 8405500L
- Authority
- SE
- Sweden
- Prior art keywords
- diagnosis
- particles
- diagnostic agent
- paramagnetic metal
- polymerized
- Prior art date
Links
- 239000002245 particle Substances 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 2
- 239000000032 diagnostic agent Substances 0.000 abstract 2
- 239000002184 metal Substances 0.000 abstract 2
- 230000005298 paramagnetic effect Effects 0.000 abstract 2
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000002285 radioactive effect Effects 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1806—Suspensions, emulsions, colloids, dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
- A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nanotechnology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8405500A SE465908B (sv) | 1984-11-01 | 1984-11-01 | Diagnosticeringspartiklar innehaallande en paramagnetisk metall |
AT85307738T ATE52032T1 (de) | 1984-11-01 | 1985-10-25 | Paramagnetische kontrastmittel fuer die anwendung in ''in vivo'' nmr-diagnostischen methoden und die herstellung davon. |
EP85307738A EP0184899B1 (en) | 1984-11-01 | 1985-10-25 | Paramagnetic contrast agents for use in "in vivo" diagnostic methods using nmr, and their preparation |
DE8585307738T DE3577185D1 (de) | 1984-11-01 | 1985-10-25 | Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon. |
NO854349A NO169525C (no) | 1984-11-01 | 1985-10-31 | Diagnostisk preparat |
DK500085A DK164486C (da) | 1984-11-01 | 1985-10-31 | Diagnostisk middel indeholdende en ikke-radioaktiv paramagnetisk metalspecies og anvendelse heraf til fremstilling af et middel til brug ved nmr- og ultralydsdiagnostik |
JP60244240A JPH0678246B2 (ja) | 1984-11-01 | 1985-11-01 | 診断用組成物 |
US06/793,899 US4985233A (en) | 1984-11-01 | 1985-11-01 | A diagnostic agent containing a non-radioactive paramagnetic metal species in a macromolecular carrier |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8405500A SE465908B (sv) | 1984-11-01 | 1984-11-01 | Diagnosticeringspartiklar innehaallande en paramagnetisk metall |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8405500D0 SE8405500D0 (sv) | 1984-11-01 |
SE8405500L true SE8405500L (sv) | 1986-05-02 |
SE465908B SE465908B (sv) | 1991-11-18 |
Family
ID=20357593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8405500A SE465908B (sv) | 1984-11-01 | 1984-11-01 | Diagnosticeringspartiklar innehaallande en paramagnetisk metall |
Country Status (1)
Country | Link |
---|---|
SE (1) | SE465908B (sv) |
-
1984
- 1984-11-01 SE SE8405500A patent/SE465908B/sv not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SE8405500D0 (sv) | 1984-11-01 |
SE465908B (sv) | 1991-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK499985A (da) | Diagnostisk middel | |
ES8704352A1 (es) | Procedimiento para preparar complejos magneticos fisiologicamente compatibles a base de un oxido-hidroxido metalico doble | |
NL191308C (nl) | Gelyofiliseerd, na oplossing injecteerbaar preparaat dat een antracycline-glycoside bevat, alsmede werkwijze voor de bereiding van een injecteerbare oplossing van een antracycline-glycoside. | |
DK377085A (da) | Diagnostikum og kontrastmiddel | |
DE3071370D1 (en) | Oligosaccharide fractions and oligosaccharides with biological properties, process for their preparation and their uses as medicines | |
IE892685L (en) | Preparation comprising cavitate- or clathrate-forming¹host/guest complexes as contrast agent | |
EP0198087A4 (en) | INFARCT DETECTOR BY MEASURING BODY SIGNALS. | |
DK1042339T3 (da) | Carbohydrater, der er egnede i faste administrationssystemer | |
WO1988006045A3 (en) | Device for the removal of active substances locally applied against solid tumors | |
IL87936A (en) | Polysulfuric acid esters of bis-aldonamides and their derivatives, their preparation and pharmaceutical compositions containing them | |
ATE101798T1 (de) | Kontrastmittel. | |
SE8405500L (sv) | Diagnosticeringspartiklar | |
EP0239970A3 (en) | Assemblage of hydroxyl apatite particles and liquid chromatography column using the same | |
EP0361490A3 (en) | Sulfated oligosaccharides and derivatives thereof | |
NL188185C (nl) | Werkwijze voor de bereiding van immunobiologische preparaten voor de diagnose, profylaxe en/of behandeling van candidainfecties, alsmede werkwijze voor de bereiding van een serum. | |
Savicki et al. | Behavioral treatment of Gilles de la Tourette syndrome. | |
SE8405501D0 (sv) | Particulate diagnostic agent | |
McKay | Assessment of frontal lobe dysfunction using the Luria-Nebraska Neuropsychological Battery—Children's Revision: A case study. | |
SE7900738L (sv) | Farmaceutiskt medel | |
GB1518813A (en) | Diagnostic agent | |
Ganesan et al. | Creativity, anxiety, time pressure and innovativeness among agricultural scientists. | |
Bogdanov et al. | Investigation of the content of C-12 and C-13 isotopes in primary cosmic rays | |
Hussain | An investigation into the creative potentialities of normal, physically handicapped and problem children. | |
Grosso | A Determination Of The Placental Permeability Of Morphine-3-Glucuronide In Guinea Pigs Using High Pressure Liquid Chromatography With Ultra-Violet Detection | |
Mathur et al. | Maternal employment and psychological differentiation in children. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8405500-3 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 8405500-3 Format of ref document f/p: F |